Breast Journal

Papers
(The TQCC of Breast Journal is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Susceptibility artifact at breast MRI due to retained fragment of localization hook‐wire hiding breast cancer36
Altered Expression of RB and pRB in Tissue Arrays of Primary Breast Cancers and Matched Axillary Lymph Node Metastases29
Issue Information22
Breast myiasis: Are we prepared for the correct diagnosis?19
The effects of vitamin D replacement on pathological complete response (pCR) in breast cancer patients receiving neoadjuvant systemic chemotherapy (NAC)15
Issue Information14
Issue Information14
Diffusion weighted imaging to predict nodal status in breast cancer: A systematic review and meta‐analysis14
Lower lymph node yield in axillary lymph node dissection specimens in breast cancer patients receiving neoadjuvant chemotherapy: Quality concern or treatment effect?13
Diagnostic concordance among pathologists interpreting breast core biopsies on secondary review over a 1‐year period at an Australian tertiary hospital13
Can one stop nucleic acid sampling (OSNA) predict nodal positivity following neoadjuvant chemotherapy? A prospective cohort study of 293 patients12
Extrapolation of ACOSOG Z0011 trial results—A survey of breast cancer providers12
Intraoperative radiation therapy or external whole‐breast irradiation, which is more effective in controlling the local recurrence of breast cancer? A Weibull regression model12
Five‐year outcomes in patients treated with surgery and radiotherapy for primary neuroendocrine neoplasm of the breast11
Abnormal screens among nonmutation carriers in the High Risk Ontario Breast Screening Program9
Clinicopathological correlates, oncological impact, and validation of Oncotype DX™ in a European Tertiary Referral Centre8
Lymphoma of the breast: A clinicopathologic analysis of 51 cases with a specific emphasis on patients with a history of breast carcinoma8
Prognostic difficulties of men with breast cancer8
Clinical Features and Prognosis Analysis of Hormone Receptor-Positive, HER2-Negative Breast Cancer with Differential Expression Levels of Estrogen and Progesterone Receptors: A 10-Year Retrospective S7
B‐cell lymphoblastic lymphoma of unilateral primary breast mass in a boy aged 11 years7
When cardiomyopathy, cancer, and COVID‐19 collide: A case report7
Contralateral prophylactic mastectomy in the setting of breast cancer diagnosis and their insurance coverage in the United States6
The significance of accurate diagnosis of encapsulated papillary carcinoma of the breast by core needle biopsy6
Breast Cancer Epidemiology and Survival Analysis of Shenyang in Northeast China: A Population-Based Study from 2008 to 20176
The Quest for Outpatient Mastectomy in COVID-19 Era: Barriers and Facilitators6
A Prospective Double-Blinded Randomized Controlled Trial Comparing the Intraoperative Injection of Technetium Tc 99m Tilmanocept with Technetium Tc 99m Sulfur Colloid in Breast Cancer Lymphatic Mappin6
Effect of Estrogen Receptor on the Relationship Between HER2 Immunohistochemistry Score and Pathological Complete Response to Neoadjuvant Treatment in HER2‐Positive Breast Cancer5
PET/CT‐Detected myofibroblastoma of the breast with bizarre cells: A potential diagnostic pitfall of malignancy5
Is There a Difference in the Diagnosis and Prognosis of Local Recurrence between Autologous Tissue and Implant-Based Breast Reconstruction?5
Use of a portable infrared 3D scanning device measuring limb volume in a safety net hospital breast clinic5
Supraclavicular Irradiation Induces Lymphedema in Breast Cancer Patients Treated with Axillary Lymph Node Dissection and Taxane‐Containing Chemotherapy5
Repeat Breast Ultrasound Demonstrates Utility with Added Cancer Detection in Patients following Breast Imaging Second Opinion Recommendations5
Time to development and imaging features of new calcifications in the treated breast after breast‐conserving therapy5
Improving time from check‐in to start with preoperative SCOUT localization5
Inhibition of Lymphangiogenesis: A Protective Role of microRNA 146a‐5p in Breast Cancer4
Factors Affecting Recurrence of Idiopathic Granulomatous Mastitis: A Systematic Review4
Assessment of the Grisotti oncoplastic procedure for the management of central breast tumors4
NOTIFICATION: The Changing Role of Pathologists from Morphologists to Molecular Pathologists in the Era of Precision Medicine4
Predicting postoperative complications following mastectomy in the elderly: Evidence for the 5‐factor frailty index4
A Single-Center 18-Year Series of 73 Cases of Metaplastic Carcinoma of the Breast4
Primary tumor resection in patients with stage IV breast cancer: 10‐year experience4
MLLT11 siRNA Inhibits the Migration and Promotes the Apoptosis of MDA-MB-231 Breast Cancer Cells4
Farewell to The Breast Journal : A novel scientific publication led by a pathologist who moved beyond the microscope and faced the patients4
Changes in utilization of axillary dissection in women with invasive breast cancer and sentinel node metastasis after the ACOSOG Z0011 trial4
Outcomes in chest feminization patients with a history of illicit hormone use and silicone injections4
Basal cell carcinoma after radiation therapy in breast cancer4
Effectiveness of Carbon Localization for Invasive Breast Cancer: An Institutional Experience4
HSV‐1 mastitis in a 30‐year‐old woman4
A single‐institution analysis of reflector‐guided localization using SAVI SCOUT® in nonpalpable breast carcinoma compared to traditional wire localization4
3
The effect of immediate breast reconstruction on adjuvant therapy delay, locoregional recurrence, and disease‐free survival3
Minimally Invasive Excision of Breast Masses under Ultrasound Guidance: A Single Center’s Five-Year Experience on the Breast Lesion Excision System3
Why women with an average risk for breast cancer undergo contralateral breast mastectomy? Does healthcare coverage matter?3
Schwannoma of the axillary region. Imaging findings, clinical pitfalls, and misdiagnosis3
Selective Capsulotomies and Partial Capsulectomy in Implant-Based Breast Reconstruction Revision Surgery3
The continued role of intraoperative assessment of the surgical margins in lumpectomy samples3
Role of tranexamic acid in axillary lymph node dissection in breast cancer patients: Does it help in reducing lymphedema?3
Study of clinico‐pathological changes before and after corticosteroid therapy in cases of idiopathic granulomatous mastitis3
Comparing the Prognoses of Breast-Conserving Surgeries for Differently Aged Women with Early Stage Breast Cancer: Use of a Propensity Score Method3
Fatal acute hepatic failure secondary to thrombotic portal venopathy after commencing abemaciclib and fulvestrant treatment for advanced breast carcinoma: a unique autopsy finding3
Synchronous breast carcinoma and peritoneal mesothelioma3
Morbidity of the Donor Site and Complication Rates of Breast Reconstruction with Autologous Abdominal Flaps: A Systematic Review and Meta-Analysis3
This is Not Only about the Biology: The Socioeconomic Disparities among African American Women with Breast Cancer Still Play a Significant Role3
3
Which Has a Greater Impact on the Recurrence in Young Breast Cancer Patients: Recent Childbirth or Recent Breastfeeding?3
Post‐surgical pyoderma gangrenosum in otherwise healthy patient with history of COVID‐193
Return to Activities of Daily Living after Breast Cancer Surgery: An Observational Prospective Questionnaire-Based Study of Patients Undergoing Mastectomy with or without Immediate Reconstruction3
Exploring the Value of Additional Primary Tumour Excision Combined with Systemic Therapy Administered in Different Sequences for Patients with de Novo Metastatic Breast Cancer3
The Prognosis and Predictive Value of Estrogen Negative/Progesterone Positive (ER−/PR+) Phenotype: Experience of 1159 Primary Breast Cancer from a Single Institute3
Analysis of Clinicopathological Characteristics and Prognosis of Carcinosarcoma of the Breast3
3
Hormonal-Receptors-Positive and HER2-Negative Patients with Metastatic Breast Cancer Treated with First-Line Palbociclib and Hormonal Therapy: Impact of First-Cycle Neutropenia and Dose Reduction on T3
0.068619966506958